Activation of NADPH oxidase in Alzheimer's disease brains
- PMID: 10873554
- DOI: 10.1006/bbrc.2000.2897
Activation of NADPH oxidase in Alzheimer's disease brains
Abstract
The present study is the first to show that superoxide (O(-)(2)) forming NADPH oxidase is activated in Alzheimer's disease (AD) brains by demonstrating the marked translocation of the cytosolic factors p47-phox and p67-phox to the membrane. In conjunction with a recent in vitro study showing that amyloid beta activates O(-)(2) forming NADPH oxidase in microglia, where these phox proteins are localized in this study, the present results suggest that, in AD, NADPH oxidase is activated in microglia, resulting in the formation of reactive oxygen species which can be toxic to neighboring neurons in AD.
Copyright 2000 Academic Press.
Similar articles
-
Prothrombin kringle-2-induced oxidative stress contributes to the death of cortical neurons in vivo and in vitro: role of microglial NADPH oxidase.J Neuroimmunol. 2009 Sep 29;214(1-2):83-92. doi: 10.1016/j.jneuroim.2009.07.005. Epub 2009 Aug 5. J Neuroimmunol. 2009. PMID: 19660816
-
NADPH oxidase as a therapeutic target in Alzheimer's disease.BMC Neurosci. 2008 Dec 3;9 Suppl 2(Suppl 2):S8. doi: 10.1186/1471-2202-9-S2-S8. BMC Neurosci. 2008. PMID: 19090996 Free PMC article. Review.
-
Melatonin impairs NADPH oxidase assembly and decreases superoxide anion production in microglia exposed to amyloid-beta1-42.J Pineal Res. 2008 Sep;45(2):157-65. doi: 10.1111/j.1600-079X.2008.00570.x. Epub 2008 Feb 19. J Pineal Res. 2008. PMID: 18298462
-
A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?IUBMB Life. 2003 Jun;55(6):307-13. doi: 10.1080/1521654031000153049. IUBMB Life. 2003. PMID: 12938732 Review.
-
Study on the superoxide-producing enzyme of eosinophils and neutrophils--comparison of the NADPH oxidase components.Arch Biochem Biophys. 1997 Sep 15;345(2):207-13. doi: 10.1006/abbi.1997.0252. Arch Biochem Biophys. 1997. PMID: 9308891
Cited by
-
Oxidative stress-mediated neuroinflammation in Alzheimer's disease.Naunyn Schmiedebergs Arch Pharmacol. 2024 Jun 4. doi: 10.1007/s00210-024-03188-3. Online ahead of print. Naunyn Schmiedebergs Arch Pharmacol. 2024. PMID: 38832985 Review.
-
Impairment of cerebral vascular reactivity and resting blood flow in early-staged transgenic AD mice: in vivo optical imaging studies.Res Sq [Preprint]. 2023 Nov 11:rs.3.rs-3579916. doi: 10.21203/rs.3.rs-3579916/v1. Res Sq. 2023. PMID: 37987006 Free PMC article. Preprint.
-
Anti-Neurodegenerating Activity: Structure-Activity Relationship Analysis of Flavonoids.Molecules. 2023 Oct 20;28(20):7188. doi: 10.3390/molecules28207188. Molecules. 2023. PMID: 37894669 Free PMC article.
-
Optogenetics in Alzheimer's Disease: Focus on Astrocytes.Antioxidants (Basel). 2023 Oct 13;12(10):1856. doi: 10.3390/antiox12101856. Antioxidants (Basel). 2023. PMID: 37891935 Free PMC article. Review.
-
Recent Mechanisms of Neurodegeneration and Photobiomodulation in the Context of Alzheimer's Disease.Int J Mol Sci. 2023 May 25;24(11):9272. doi: 10.3390/ijms24119272. Int J Mol Sci. 2023. PMID: 37298224 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical